Critical Care

official impact factor 4.60

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access

Gram-negative antibiotic resistance: there is a price to pay

Thomas G Slama

Critical Care 2008, 12(Suppl 4):S4 doi:10.1186/cc6820

Accesses  

  • Last 30 days: 183 accesses
  • Last year: 2572 accesses
  • All time: 13424 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007

Ji-Guang Ding, Qing-Feng Sun, Ke-Cheng Li, Ming-Hua Zheng, Xiao-Hui Miao, Wu Ni, Liang Hong, Jin-Xian Yang, Zhan-Wei Ruan, Rui-Wei Zhou, Hai-Jiao Zhou, Wen-Fei He BMC Infectious Diseases 2009, 9:115 (25 July 2009)

Introduction   Free Highly Accessed

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Reuben Ramphal Critical Care 2008, 12(Suppl 4):S1 (21 May 2008)